Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Change in Accured Expenses (2016 - 2026)

Pediatrix Medical (MD) has disclosed Change in Accured Expenses for 17 consecutive years, with $67.2 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 21.25% to $67.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $28.3 million through Dec 2025, down 44.6% year-over-year, with the annual reading at $28.3 million for FY2025, 44.6% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was $67.2 million at Pediatrix Medical, up from $51.1 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $158.4 million in Q2 2022, with the low at -$159.3 million in Q1 2022.
  • Average Change in Accured Expenses over 5 years is $1.4 million, with a median of $34.4 million recorded in 2023.
  • The sharpest move saw Change in Accured Expenses soared 536.32% in 2023, then plummeted 243.14% in 2025.
  • Over 5 years, Change in Accured Expenses stood at -$17.2 million in 2021, then surged by 162.33% to $10.7 million in 2022, then surged by 157.34% to $27.6 million in 2023, then surged by 208.92% to $85.3 million in 2024, then decreased by 21.25% to $67.2 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $67.2 million, $51.1 million, and -$83.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.